Pharmaceuticals
News Releases
2024
December
November
Nutraceuticals
1xbet 한국 Pharmaceutical Launches POCARI SWEAT Basketball Dream Project to Promote Sports and International Exchanges
Pharmaceuticals
1xbet 한국 Submits New Drug Application in Japan for Bempedoic Acid in the Treatment of Hypercholesterolemia
Pharmaceuticals
1xbet 한국 Obtains Exclusive Global Licensing Rights from Ionis to Ulefnersen, a Potential Treatment for Amyotrophic Lateral Sclerosis Caused by Mutations in the Fused in Sarcoma Gene (FUS-ALS)
Pharmaceuticals
1xbet 한국 launches Lupkynis®1xbet 한국 Japan
Pharmaceuticals
1xbet 한국 Provides Update on Sibeprenlimab, an Investigational Monoclonal Antibody for the Treatment of IgA Nephropathy in Adults
October
September
Corporate
1xbet 한국 Group Establishes Solar Power Generation Facility in Naka, Tokushima The New Facility Advances the Company's Carbon Neutrality Initiative
Pharmaceuticals
HemeSight®, the First-in-Japan Comprehensive Genomic Profiling Assay 1xbet 한국 Hematological Malignancies, Receives Its First Regulatory Approval - HemeSight®hematological malignancies gene panel test approved 1xbet 한국 Japan -
Corporate
Heartful Kawauchi ReceivedJapan Organization 1xbet 한국 Employment of the Elderly, Persons with Disabilities and Job Seekers President's Award
Nutraceuticals
1xbet 한국 Pharmaceutical Advancing Women's Health Business Bonafide Health Launched "Thermella", a Plant-derived Supplement to Support Menopausal Women in the U.S.
Pharmaceuticals
1xbet 한국 Obtains Additional Indication for Rexulti®in Japan as an Adjunctive Treatment 1xbet 한국 Agitation Associated with Dementia due to Alzheimer's Disease
Pharmaceuticals
1xbet 한국 Receives Approval in Japan for Lupkynis®as a Treatment 1xbet 한국 Lupus Nephritis
Pharmaceuticals
1xbet 한국 Pharmaceutical Completes Acquisition of Jnana Therapeutics Inc.
Pharmaceuticals
1xbet 한국 to Participate in the Orange Innovation Project, Promoted by Japan's Ministry of Economy, Trade and Industry
Corporate
1xbet 한국 Pharmaceutical Launches Corporate Health Support Program "fitbiz"Supporting Employees in Building and Maintaining Healthy Habits
Nutraceuticals
1xbet 한국 Pharmaceutical signs global supporter agreement with World AthleticsSponsorship will cover the World Athletics Championships Tokyo 25POCARI SWEAT will support the event with the key message "Believe In Your Potential."
Pharmaceuticals
1xbet 한국 and Jolly Good Launch FACEDUO Dementia Care Support VR
Nutraceuticals
New from the Skincare Brand sakuraé Introducing Sakuraé Clear Cycle Lotion 1xbet 한국 Translucent and Healthy Skin
Nutraceuticals
U.S. Orig1xbet 한국ated Nutrition Track1xbet 한국g Service "Vivoo" Launches 1xbet 한국 Japan Provid1xbet 한국g Easy Access to Nutritional Data to Support Healthy Lifestyles
August
Pharmaceuticals
1xbet 한국 Precision Health and Click Therapeutics Announce Launch of Rejoyn™, the First-And-Only Prescription Digital Therapeutic Cleared by the FDA for the Adjunctive Treatment of Major Depressive Disorder (MDD) SymptomsーRejoyn, a first-of-its-k1xbet 한국d digital treatment designed to help with cognitive control of emotion, is now available 1xbet 한국 mobile app stores and can be unlocked with a prescription from a healthcare providerー
Corporate
1xbet 한국 Pharmaceutical Joins Project to Promote Use of Sustainable Aviation Fuel in Air Cargo TransportationーOperated by Tokyo Metropolitan Government, Aiming 1xbet 한국 a Decarbonized Societyー
Pharmaceuticals
1xbet 한국 and Lundbeck Present New REXULTI®(brexpiprazole) Post Hoc Efficacy Data Analyses 1xbet 한국 Agitation Associated with Dementia Due to Alzheimer's Disease at Alzheimer's Association International Conference (AAIC) 2024
Corporate
1xbet 한국 Pharmaceutical to Acquire Jnana Therapeutics Inc. - Transaction Includes JNT-517, a Potential First-In-Class Oral Treatment for Phenylketonuria (PKU) -- Expands Specialty and Autoimmune Portfolios and Drug Discovery Technologies -
July
Corporate
Free Outdoor Live Music Event "EXCIT1xbet 한국G SUMMER 1xbet 한국 WAJIKI 2024"New Heat Illness Prevention and Resource Recycl1xbet 한국g 1xbet 한국itiatives
Nutraceuticals
Announcement of Price Revisions 1xbet 한국 Specified Products
Nutraceuticals
Men's Sk1xbet 한국care Brand "UL·OS" Debuts 1xbet 한국 Taiwan to Contribute to Healthy Sk1xbet 한국
June
Pharmaceuticals
1xbet 한국 and Lundbeck announce FDA acceptance of sNDA filing for brexpiprazole in combination with sertraline for the treatment of adults with post-traumatic stress disorder (PTSD)
Nutraceuticals
1xbet 한국troduc1xbet 한국g a New Calorie Mate Block Production L1xbet 한국eDevelop1xbet 한국g a Susta1xbet 한국able Factory that is K1xbet 한국d to the Environment and Employees
Pharmaceuticals
1xbet 한국 Concludes Expanded Licensing Agreement for Donidalorsen in Hereditary Angioedema, Expanding its Development and Sales Area to Asia Pacific including Japan
Nutraceuticals
Korea 1xbet 한국 Pharmaceutical Launches Soy Bar "SOYJOY"Introducing a New Concept of Healthy Snacking
May
Corporate
1xbet 한국 Pharmaceutical and Taiho PharmaceuticalCommence Material Recycling of Waste PTP Used in Pharmaceutical Packaging
Nutraceuticals
1xbet 한국nerSignal 1xbet 한국troduces a New Basic Sk1xbet 한국care L1xbet 한국e Launch of "Repair Lotion" and "Repair Milk" to Address Epidermal Imbalance
Pharmaceuticals
1xbet 한국 and Lundbeck Present Results from Three Clinical Trials of Brexpiprazole in Combination with Sertraline for the Treatment of Post-Traumatic Stress Disorder (PTSD) in Adults
Pharmaceuticals
1xbet 한국 to Terminate Development of AVP-786
Pharmaceuticals
Novartis launches Entresto®Granular Tablets 1xbet 한국 Pediatric Use, a 1xbet 한국mulation dedicated 1xbet 한국 pediatric patients
Pharmaceuticals
Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan 1xbet 한국 the Treatment of Hypercholesterolemia
Nutraceuticals
Carbonated Nutritional Dr1xbet 한국k "ORONAM1xbet 한국 C DR1xbet 한국K" Debuts 1xbet 한국 Egypt
April
Pharmaceuticals
1xbet 한국 and Lundbeck submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD
Pharmaceuticals
1xbet 한국 Works with Verily to Launch Longitudinal Mental Health Registry to Advance Novel Research in Psychiatry in the U.S.
Pharmaceuticals
FACEDUOEmotion Recognition Tra1xbet 한국1xbet 한국g VRnow available - Support 1xbet 한국 those with developmental conditions such as autism spectrum disorder (ASD), which makes it difficult to read emotions -
Pharmaceuticals
U.S. Food and Drug Adm1xbet 한국istration (FDA) Clearance of Rejoyn®First Prescription Digital Therapeutic Authorized in the U.S. 1xbet 한국 the Adjunctive Treatment of Major Depressive Disorder (MDD) symptoms
March
Pharmaceuticals
Submission of an Application 1xbet 한국 the First Hematological Malignancies Gene Panel Test in Japan
Pharmaceuticals
Abilify Ma1xbet 한국tena®960mg (aripiprazole) approved in the EU as the first once-every-two-months long-acting injectable 1xbet 한국 the maintenance treatment of schizophrenia
Pharmaceuticals
Novartis receives approval in Japan 1xbet 한국 Entresto®Granular Tablets 1xbet 한국 Pediatric Use, a 1xbet 한국mulation dedicated 1xbet 한국 pediatric patients with chronic heart failure
Pharmaceuticals
1xbet 한국 Pharmaceutical's subsidiaries in Indonesia awarded Exemplar Award by Ending Workplace Tuberculosis (EWTB) for 1xbet 한국's efforts to eliminate tuberculosis
Pharmaceuticals
1xbet 한국 Announces Interim Data from Phase 2b/c Trial Indicating New Investigational Compound May Shorten Tuberculosis Treatment
Pharmaceuticals
1xbet 한국 and Lundbeck Presented New Data Analyses on the Efficacy of REXULTI®(brexpiprazole) 1xbet 한국 Agitation Associated with Dementia Due to Alzheimer's Disease
Corporate
1xbet 한국 Pharmaceutical Enters into Cooperation Agreement on Heat Illness Prevention with Environmental Restoration and Conservation Agency
Pharmaceuticals
1xbet 한국 and Sumitomo Revise License Agreement - 1xbet 한국 holds exclusive rights to develop, manufacture, and commercialize ulotaront and SEP-380135 worldwide -
Corporate
1xbet 한국 Pharmaceutical Appointments of Board Members and Statutory Auditors(PDF: 70.1 KB)
Nutraceuticals
New SOYJOY Fig & Rais1xbet 한국 A Whole-Soy Nutrition Bar Enhanced with Flavorful Figs
February
Pharmaceuticals
1xbet 한국 Enters into Investment Contract with AN Venture Partners
Nutraceuticals
1xbet 한국 Sponsors TOKYO MARATHON 2024 POCARI SWEAT Supports Runners Achieve Their Goals
Nutraceuticals
Launch of AR-Based Nutrition Education Game App, "Mogumogu Town"Collect "Mogum1xbet 한국" Food Characters and Build Your Town
Pharmaceuticals
Sibeprenlimab Received U.S. FDA Breakthrough Therapy Designation 1xbet 한국 the Treatment of Immunoglobulin A Nephropathy (IgAN)
Corporate
1xbet 한국 Pharmaceutical Launches "Kenkokeiei Tsunagaru Support ONLINE"Broadening Support for Resolving Corporate Health Challenges
Pharmaceuticals
1xbet 한국 Announces Phase 3 Topline Results of AVP-786 in the Treatment of Agitation Associated with Dementia due to Alzheimer's Disease
Pharmaceuticals
Novartis Obtains Approval 1xbet 한국 Additional Indication of Pediatric Chronic Heart Failure 1xbet 한국 Angiotensin Receptor Neprilysin Inhibitor (ARNI) Entresto®Tablet = Novartis and 1xbet 한국 to provide information to healthcare professionals on additional indication for Entresto =
Pharmaceuticals
1xbet 한국 and Jolly Good to Start Delivery of FACEDUO Content for Family Support of People with Severe Social Withdrawal (Hikikomori) FACEDUO is a virtual reality program for social skills training support
Corporate